**Author details**

Sivapatham Sundaresan\* and Palanirasu Rajapriya Department of Medical Research, SRM MCH RC, SRM IST, Kattankulathur-603203, Chengalpattu DT, Tamilnadu, India

\*Address all correspondence to: ssunsrm@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**71**

*Translational Perspective in Hepatocellular Carcinoma DOI: http://dx.doi.org/10.5772/intechopen.94769*

[11] Anfuso B, El-Khobar KE,

origin of cancer stem cells in

[12] Friemel J, et al. Intratumor heterogeneity in hepatocellular carcinoma. Clin. Cancer Res.

(Suppl 1):S92-97.

2015;21:1951-1961.

2016;24:11-29.

2016;278:563-577.

2013;33:1653-1668.

2016;44:856-864.

1999;19:329-38.

[17] Hectors SJ, et al. Intravoxel incoherent motion diffusionweighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI? J. Magn. Reson. Imaging.

[18] Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis.

[19] Kow AW. Transplantation versus liver resection in patients with

Sukowati CH, Tiribelli C. The multiple

hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 2015;39

[13] Abramson RG, et al. MR Imaging Biomarkers in Oncology Clinical Trials. Magn. Reson. Imaging Clin. N. Am.

[14] Fujita N, et al. Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging. Eur. Radiol. 2015;25:211-220.

[15] Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology.

[16] McEvoy SH, et al. Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Diseases. Radiographics.

[1] Acharya SK. Epidemiology of hepatocellular carcinoma in India. Journal of clinical and experimental

[2] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.

[3] EASL–EORTC Clinical Practice

hepatocellular carcinoma. J Hepatol.

[4] Abou-Alfa GK. Hepatocellular carcinoma: molecular biology and therapy. Semin Oncol. 2006;33:S79–S83.

[5] Kumari R, Sahu MK, Tripathy A, Uthansingh K, Behera M. Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepatic Oncology. 2018;

[6] Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD.

Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology.

[7] Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2012;12(3):530.

Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology.

[9] Crissien AM, Frenette C. Current management of hepatocellular carcinoma. Gastroenterology & hepatology. 2014;10(3):153.

[10] Singh D, Das CJ, Baruah MP. Imaging of nonalcoholic fatty liver disease: A road less travelled. Indian J Endocrinol Metab. 2013;17:990-995.

Guideline Management of

hepatology. 2014; 4: S27-33.

2010;127: 2893-2917.

2012; 56:908-943.

5:HEP08.

2009; 21;15:1301.

[8] Gomaa AI, Khan SA,

2009;15(11):1301.

**References**

*Translational Perspective in Hepatocellular Carcinoma DOI: http://dx.doi.org/10.5772/intechopen.94769*
